Skip to main content
Tetra Bio-Pharma Inc. logo

Tetra Bio-Pharma Inc. — Investor Relations & Filings

Ticker · TBPMQ ISIN · CA88166Y1007 LEI · 5299000CYH3P8XC2UO53 TSX Manufacturing
Open in API
Filings indexed 720 across all filing types
Latest filing 2020-03-30 Regulatory Filings
Country CA Canada
Listing TSX TBPMQ

About Tetra Bio-Pharma Inc.

https://tetrabiosciences.com/

Tetra Bio-Pharma is a biopharmaceutical company specializing in the discovery and development of cannabinoid-derived drugs and medicinal plant-based products. The company maintains an advanced pipeline encompassing biopharmaceuticals, natural health, and veterinary products. Clinical programs are focused on therapeutic areas such as inflammation, pain management (including alternatives to opioids), and ophthalmology. Tetra emphasizes rigorous clinical trials and scientific evidence, utilizing novel approaches, unique mechanisms of action, and high-quality delivery methods to address unmet patient needs.

Recent filings

Filing Released Lang Actions
52-109F1R - Certification of refiled annual filings - CFO (E).pdf
Regulatory Filings
2020-03-30 English
Annual MD&A (amended) - English.pdf
Regulatory Filings
2020-03-30 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2020-03-28 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual financial statements and MD&A for the financial year ended November 30, 2018. The document is primarily an officer certification letter and does not contain actual financial data or the full annual report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) or Management Reports (MDA). The document length is short (3034 characters), consistent with a certification letter rather than a full report.
2020-03-28 English
News release - English.pdf
Regulatory Filings
2020-03-26 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of the annual financial statements and MD&A for the financial year ended November 30, 2019. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the annual filings but does not include them. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or Management Reports (MDA). The document length is short (3017 characters), consistent with a certification letter rather than a full report.
2020-03-26 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.